Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
110
NCT00121745
Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2005
Completion: Jul 31, 2007
NCT00504998
Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer
Phase: Phase 1/2
Start: Jul 31, 2007
Completion: Jun 30, 2011
NCT00505271
Safety and Efficacy Study Using Rexin-G for Breast Cancer
NCT00505713
Safety and Efficacy Study Using Rexin-G for Sarcoma
NCT00572130
Phase II Study of Intravenous Rexin-G in Osteosarcoma
Phase: Phase 2
Start: Dec 31, 2007